The present invention relates to 4-(substituted anilino)-quinazolinederivativesas tyrosine kinase inhibitors. Specifically, compounds of formula I, orpharmaceutically acceptable salts or solvates thereof are disclosed, in whicheachsubstitutent in formula I is defined in the description. Preparation method ofthecompounds of formula I, pharmaceutical compositons and pharmaceutical usesthereof are also disclosed. The compounds of formula I are effective tyrosinekinaseinhibitors.(see formula I)